Le Lézard
Classified in: Health
Subject: FDA

SmartCardia Receives FDA Clearance for its 14-Day 7-Lead ECG Real-Time Patch and Cloud Platform


LAUSANNE, Switzerland, Sept. 15, 2023 /PRNewswire/ -- SmartCardia has received FDA clearance for its 7-lead real-time ECG monitoring patch and cloud platform. SmartCardia's 7L patch is easy-to-wear, cable-free, waterproof and can be used for continuous monitoring for up to 14 days.

"SmartCardia's 7L patch and cloud platform is a single solution that covers the entire spectrum of cardiac monitoring including screening, post-operative follow-up, and remote patient monitoring. It has been designed ground-up to meet the stringent requirements of these different applications", said Srinivasan Murali, co-founder and CEO of SmartCardia.

One of the major limitations of cardiac patches in the market is the lack of multiple, reciprocal leads that enable accurate arrhythmia detection. SmartCardia's 7L patch provides excellent P and QRS waves, unprecedented signal quality and allows for accurate detection of arrhythmias thanks to its 7 ECG leads.

According to the CTO, Francisco Rincon: "100% of the ECG data, not just events, is transmitted in real-time, and the automated analysis is performed throughout the entire signal. While full-disclosure analysis allows for highly accurate arrhythmia detection, easy navigation on the cloud platform allows the clinician to quickly view and analyze ECG at any point in time."

The 7L platform features real-time view of the patient's ECG and can deliver visual and audio alarms. It also provides automatic trigger of abnormal events with notifications to clinicians, and analysis of a comprehensive set of arrhythmias.

The patch and cloud platform are CE Class IIa approved. SmartCardia is expanding its global footprint with widespread adoption in Europe and India and quickly reaching new geographies. The company has been recognized by Frost & Sullivan with the 2022 Global New Product Innovation Award in cardiac monitoring.

About SmartCardia:

SmartCardia is a leading provider of an integrated cloud platform and patch for cardiac and remote patient monitoring. Integrating accurate ECG and vital sign data with clinician cloud SaaS platform enables SmartCardia to provide actionable insights into patients' health. The solution provides excellent clinical, operational, and financial benefits to hospitals and patients globally.

SOURCE SmartCardia


These press releases may also interest you

at 04:37
The depository receipt holders of Implantica AG, reg. no. FL-0002.629.889-3, are hereby invited to attend the annual general meeting to be held on Wednesday, May 22, 2024, at 14:30 at Hotel Kommod, Industriering 14, 9491 Ruggell, Liechtenstein....

at 04:15
Fastest Labs, a leading national drug, alcohol, and DNA testing company, is expanding its presence in North Carolina with a new franchise location in Wilmington, NC. The move marks a significant stride in the company's efforts to provide fast,...

at 04:15
The Circularity in Primary Pharmaceutical Packaging Accelerator (CiPPPA) initiative launched this week to tackle the challenges of recycling medicinal devices and pharmaceutical packaging. The pharmaceutical industry faces recycling difficulties due...

at 04:06
Local and global experts are meeting in Nairobi, Kenya to update clinical practice guidelines as part of ongoing work with Allied Against Cancer?a collaboration between the National Comprehensive Cancer Network® (NCCN®), African...

at 04:00
Ellipses Pharma Limited ("Ellipses"), a global drug development company focused on accelerating the development of cancer treatments through an innovative drug development model, announced today the U.S. Food and Drug Administration (FDA) has...

at 02:30
On April 30th, 2024, in celebration of Mental Health Awareness Month and AAPI Heritage Month,  international award-winning classical pianist and pop-R&B singer Janet Noh released her newest record 'Oh Child' as well as its accompanying cinematic...



News published on and distributed by: